Literature DB >> 25643733

Osteosarcoma tissues and cell lines from patients with differing serum alkaline phosphatase concentrations display minimal differences in gene expression patterns.

L C de Sá Rodrigues1, K E Holmes1, V Thompson1, C M Piskun1, S E Lana2, M A Newton3,4, T J Stein1,4,5.   

Abstract

Serum alkaline phosphatase (ALP) concentration is a prognostic factor for osteosarcoma in multiple studies, although its biological significance remains incompletely understood. To determine whether gene expression patterns differed in osteosarcoma from patients with differing serum ALP concentrations, microarray analysis was performed on 18 primary osteosarcoma samples and six osteosarcoma cell lines from dogs with normal and increased serum ALP concentration. No differences in gene expression patterns were noted between tumours or cell lines with differing serum ALP concentration using a gene-specific two-sample t-test. Using a more sensitive empirical Bayes procedure, defective in cullin neddylation 1 domain containing 1 (DCUN1D1) was increased in both the tissue and cell lines of the normal ALP group. Using quantitative PCR (qPCR), differences in DCUN1D1 expression between the two groups failed to reach significance. The homogeneity of gene expression patterns of osteosarcoma associated differing serum ALP concentrations are consistent with previous studies suggesting serum ALP concentration is not associated with intrinsic differences of osteosarcoma cells.
© 2015 John Wiley & Sons Ltd.

Entities:  

Keywords:  cell signalling; comparative oncology; genetics; oncology; tumour biology

Mesh:

Substances:

Year:  2015        PMID: 25643733      PMCID: PMC4841739          DOI: 10.1111/vco.12132

Source DB:  PubMed          Journal:  Vet Comp Oncol        ISSN: 1476-5810            Impact factor:   2.613


  41 in total

1.  The prognostic value of serum alkaline phosphatase in osteosarcoma of the limbs.

Authors:  G Bacci; D Dallari; A Battistini; M Orlandi; S Ferrari; M Avella; P Picci; R Casadei; P Ruggieri
Journal:  Chir Organi Mov       Date:  1992 Apr-Jun

2.  Prognostic factors of early metastasis and mortality in dogs with appendicular osteosarcoma after receiving surgery: an individual patient data meta-analysis.

Authors:  A F Schmidt; M Nielen; O H Klungel; A W Hoes; A de Boer; R H H Groenwold; J Kirpensteijn
Journal:  Prev Vet Med       Date:  2013-09-03       Impact factor: 2.670

3.  Relationships between serum biomarker levels and clinical presentation of human osteosarcomas.

Authors:  Sakkadech Limmahakhun; Peraphan Pothacharoen; Nipon Theera-Umpon; Olarn Arpornchayanon; Taninnit Leerapun; Sirichai Luevitoonvechkij; Dumnoensun Pruksakorn
Journal:  Asian Pac J Cancer Prev       Date:  2011

4.  Prognostic significance of serum alkaline phosphatase activity in canine appendicular osteosarcoma.

Authors:  C K Garzotto; J Berg; W E Hoffmann; W M Rand
Journal:  J Vet Intern Med       Date:  2000 Nov-Dec       Impact factor: 3.333

5.  Clinical utility of biochemical bone turnover markers in children and adolescents with osteosarcoma.

Authors:  J Ambroszkiewicz; J Gajewska; T Klepacka; M Chełchowska; T Laskowska-Klita; W Woźniak
Journal:  Adv Med Sci       Date:  2010       Impact factor: 3.287

6.  Canine osteosarcoma cell lines from patients with differing serum alkaline phosphatase concentrations display no behavioural differences in vitro.

Authors:  K E Holmes; V Thompson; C M Piskun; R A Kohnken; M K Huelsmeyer; T M Fan; T J Stein
Journal:  Vet Comp Oncol       Date:  2013-03-12       Impact factor: 2.613

7.  Impact of telomerase status on canine osteosarcoma patients.

Authors:  K Kow; D H Thamm; J Terry; K Grunerud; S M Bailey; S J Withrow; S E Lana
Journal:  J Vet Intern Med       Date:  2008-08-25       Impact factor: 3.333

8.  Prognostic significance of serum alkaline phosphatase measurements in patients with osteosarcoma treated with adjuvant or neoadjuvant chemotherapy.

Authors:  G Bacci; P Picci; S Ferrari; M Orlandi; P Ruggieri; R Casadei; A Ferraro; R Biagini; A Battistini
Journal:  Cancer       Date:  1993-02-15       Impact factor: 6.860

9.  Prognostic importance of alkaline phosphatase activity in serum from dogs with appendicular osteosarcoma: 75 cases (1990-1996).

Authors:  N Ehrhart; W S Dernell; W E Hoffmann; R M Weigel; B E Powers; S J Withrow
Journal:  J Am Vet Med Assoc       Date:  1998-10-01       Impact factor: 1.936

10.  Expression profiling in canine osteosarcoma: identification of biomarkers and pathways associated with outcome.

Authors:  Liza E O'Donoghue; Andrey A Ptitsyn; Debra A Kamstock; Janet Siebert; Russell S Thomas; Dawn L Duval
Journal:  BMC Cancer       Date:  2010-09-22       Impact factor: 4.430

View more
  2 in total

1.  An evaluation of TAZ and YAP crosstalk with TGFβ signalling in canine osteosarcoma suggests involvement of hippo signalling in disease progression.

Authors:  Anita K Luu; Courtney R Schott; Robert Jones; Andrew C Poon; Brandon Golding; Roa'a Hamed; Benjamin Deheshi; Anthony Mutsaers; Geoffrey A Wood; Alicia M Viloria-Petit
Journal:  BMC Vet Res       Date:  2018-11-26       Impact factor: 2.741

2.  A Scoring System for Predicting Neoadjuvant Chemotherapy Response in Primary High-Grade Bone Sarcomas: A Multicenter Study.

Authors:  Fangzhou He; Lu Xie; Xin Sun; Jie Xu; Yuan Li; Rong Liu; Kunkun Sun; Danhua Shen; Jin Gu; Tao Ji; Wei Guo
Journal:  Orthop Surg       Date:  2022-08-26       Impact factor: 2.279

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.